Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

3.7K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
3.7K
Embryonic Stem Cells00:57

Embryonic Stem Cells

4.5K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
4.5K
Stem Cell Culture01:17

Stem Cell Culture

4.5K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
4.5K
iPS Cell Differentiation01:22

iPS Cell Differentiation

2.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Degenerative Scoliosis Correction Is Safe in Elderly Patients with Coronary Artery Disease.

Journal of clinical medicine·2026
Same author

International Society for Human and Animal Mycology (ISHAM) One Health Sporotrichosis Working Group Proceedings-Bogota, Colombia, 2024 INFOCUS Conference.

Medical mycology·2025
Same author

Corrigendum to "Timing of external ventricular drain placement and its effects on in-hospital outcomes in traumatic brain injury: A propensity score-matched analysis" [Clin. Neurol. Neurosurg. 257 (2025) 109044].

Clinical neurology and neurosurgery·2025
Same author

Timing of external ventricular drain placement and its effects on in-hospital outcomes in traumatic brain injury: A propensity score-matched analysis.

Clinical neurology and neurosurgery·2025
Same author

Repeated non-hemorrhagic and non-contusional mild traumatic brain injury in rats elicits behavioral impairment with microglial activation, astrogliosis, and tauopathy: Reproducible and quantitative model of chronic traumatic encephalopathy.

Brain research·2025
Same author

Enhancing Glioblastoma Resection with NIR Fluorescence Imaging: A Systematic Review.

Cancers·2024

Related Experiment Video

Updated: Apr 25, 2026

Embryonic Stem Cell-Derived Endothelial Cells for Treatment of Hindlimb Ischemia
09:11

Embryonic Stem Cell-Derived Endothelial Cells for Treatment of Hindlimb Ischemia

Published on: January 23, 2009

11.1K

Stem cell therapy for neonatal hypoxic-ischemic encephalopathy.

Gabriel S Gonzales-Portillo1, Stephanny Reyes1, Daniela Aguirre1

  • 1Department of Neurosurgery and Brain Repair, University of South Florida , Tampa, FL , USA.

Frontiers in Neurology
|August 28, 2014
PubMed
Summary

Stem cell therapy shows promise for neonatal hypoxic-ischemic encephalopathy (HIE). This review guides research by examining animal models, stem cell sources, and safety, adapting stroke guidelines for HIE.

Keywords:
cerebral palsycombination therapyhypothermiastem cellstranslational research

More Related Videos

Early Pathological and Magnetic Resonance Detection of Cerebral Injury Using a Rat Model of Neonatal Hypoxic Ischemic Encephalopathy
05:52

Early Pathological and Magnetic Resonance Detection of Cerebral Injury Using a Rat Model of Neonatal Hypoxic Ischemic Encephalopathy

Published on: October 28, 2022

888
The Hypoxic Ischemic Encephalopathy Model of Perinatal Ischemia
08:47

The Hypoxic Ischemic Encephalopathy Model of Perinatal Ischemia

Published on: November 19, 2008

35.4K

Related Experiment Videos

Last Updated: Apr 25, 2026

Embryonic Stem Cell-Derived Endothelial Cells for Treatment of Hindlimb Ischemia
09:11

Embryonic Stem Cell-Derived Endothelial Cells for Treatment of Hindlimb Ischemia

Published on: January 23, 2009

11.1K
Early Pathological and Magnetic Resonance Detection of Cerebral Injury Using a Rat Model of Neonatal Hypoxic Ischemic Encephalopathy
05:52

Early Pathological and Magnetic Resonance Detection of Cerebral Injury Using a Rat Model of Neonatal Hypoxic Ischemic Encephalopathy

Published on: October 28, 2022

888
The Hypoxic Ischemic Encephalopathy Model of Perinatal Ischemia
08:47

The Hypoxic Ischemic Encephalopathy Model of Perinatal Ischemia

Published on: November 19, 2008

35.4K

Area of Science:

  • Neuroscience
  • Regenerative Medicine
  • Neonatal Research

Background:

  • Neonatal hypoxic-ischemic encephalopathy (HIE) has limited treatment options.
  • HIE shares pathologies with stroke, suggesting potential for cell-based therapies.
  • Existing stroke research provides a foundation for HIE therapeutic development.

Purpose of the Study:

  • To provide translational research guidance for stem cell therapy in neonatal HIE.
  • To examine clinically relevant animal models, stem cell sources, and assay endpoints.
  • To adapt existing stroke guidelines (STEPS) to neonatal needs (Baby STEPS).

Main Methods:

  • Review of preclinical animal models for HIE.
  • Analysis of potential stem cell sources for therapeutic application.
  • Evaluation of safety and efficacy assays for stem cell therapies.
  • Adaptation of the STEPS guidelines to the Baby STEPS framework for neonatal HIE.

Main Results:

  • Neonatal HIE presents distinct clinical features compared to adult stroke.
  • Clinically relevant animal models and stem cell sources are identified.
  • Established safety and efficacy assays are crucial for clinical translation.
  • The Baby STEPS guidelines offer a tailored approach for HIE cell therapy.

Conclusions:

  • Stem cell therapy holds significant potential for treating neonatal HIE.
  • Translational guidance, including adapted guidelines and robust assays, is essential for clinical implementation.
  • Combination therapies, potentially with hypothermia, may enhance treatment efficacy.